Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets
Authors:
Open Access
- 19 October 2017
- journal article
- Published by American Society of Hematology in Blood
- Vol. 130 (16) , 1819-1831
Abstract
Key Points: Adult-mBLs have distinct and more frequent DNA copy number abnormalities compared with pediatric-mBL. Comprehensive genomic analysis revealed that the BCR signaling pathway is a potential therapeutic target in adult-mBL.Keywords
This publication has 57 references indexed in Scilit:
- The genetic landscape of mutations in Burkitt lymphomaNature Genetics, 2012
- Therapeutic Targeting of the Cyclin D3:CDK4/6 Complex in T Cell LeukemiaCancer Cell, 2012
- Mutant p53: one name, many proteinsGenes & Development, 2012
- Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosisBlood, 2012
- Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profilingBlood, 2012
- Genome wide copy number analysis of paediatric Burkitt lymphoma using formalin‐fixed tissues reveals a subset with gain of chromosome 13q and corresponding miRNA over expressionBritish Journal of Haematology, 2011
- Cyclin D3 Is Selectively Required for Proliferative Expansion of Germinal Center B CellsMolecular and Cellular Biology, 2011
- Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledgeLeukemia, 2008
- Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathwaysProceedings of the National Academy of Sciences, 2008
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005